Brivaracetam Shows Promise For Juvenile Myoclonic Epilepsy
This study looked at brivaracetam (BRV) used alone as the initial seizure medicine in patients with juvenile myoclonic epilepsy (JME).
This hub covers epilepsy comorbidities, which are the other conditions that often show up alongside seizures (like ADHD, anxiety, depression, autism, and sleep issues). Plain-language research takeaways for families.
Often both. Shared brain networks, stress, sleep disruption, and medication effects can all contribute.
Track timing: New symptoms after med changes or dose increases may point to side effects.
If school is hard, attention/memory changes, or thereβs concern about learning, yes, it can guide supports.
Sometimes. Improving sleep and stress can reduce seizure susceptibility in some people.
This study looked at brivaracetam (BRV) used alone as the initial seizure medicine in patients with juvenile myoclonic epilepsy (JME).
This paper was a systematic review that looked at studies directly comparing two noninvasive brain stimulation methods: transcranial alternating current stimulation (tACS) and transcranial direct current stimulation (tDCS).
This was a small early study of prescription cannabidiol (CBD, brand name Epidiolex) in 12 children and teens with refractory epilepsy.
Researchers used data from a large Norwegian pregnancy and child study to examine whether children born to women with epilepsy may carry higher common genetic susceptibility for ADHD or autism spectrum disorder than other children.
This study looked at whether a blood marker called neurofilament light chain, or NfL, was linked to depressive symptoms in adults with epilepsy.
This study looked at whether people with epilepsy have higher levels of tau, a protein linked to brain disease, even when they do not have dementia.
This study looked at how a single session of exercise may change brain activity linked to memory.
This study looked at how sleep relates to thinking skills and later dementia risk in people with focal epilepsy.
This study looked at pregnancy outcomes in women with intellectual disabilities in California.